Indefinite Delivery Contract SPE2DX15D9127

The Defense Logistics Agency (DLA) Troop Support Medical awarded an Indefinite Delivery Contract (IDC) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, with a potential value of up to $499,999,999 through November 2026. This IDC enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the recurring medical supply needs of military healthcare facilities and veterans' medical centers nationwide.

The awarded delivery orders, which do not have any set-aside designations, total over $2.1 million and cover a diverse array of pharmaceutical products such as flumazenil injection, prednisone tablets, epinephrine auto-injectors, and specialized medications like Xolair, Trikafta, Keytruda, Botox, and Nucala. These delivery orders are issued against the overarching IDC held by DMS Pharmaceutical Group and are predominantly for firm fixed-price supplies to be delivered to the DLA's medical facility in Park Ridge, Illinois. As a key supplier in the federal pharmaceutical supply chain, DMS Pharmaceutical Group has consistently demonstrated its capability to provide a wide range of medical products and services to support the Department of Defense's healthcare requirements.